Pharmacological inhibitors of cyclin-dependent kinases (CDKS) and glycogen synthast kinase-3 (GSK-3).

被引：0
|
作者：
Meijer, L [1 ]
机构：
[1] Ctr Natl Rech Sci, Stn Biol, Roscoff, France
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 226卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
238-COMP
引用
收藏
页码：U460 / U460
页数：1
相关论文
共 50 条
  • [41] Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as a New Lead for Treat-ing Breast and Ovarian Cancer
    Chandra, Phool
    Sachan, Neetu
    Pal, Dilipkumar
    CURRENT DRUG TARGETS, 2021, 22 (13) : 1548 - 1554
  • [42] A novel class of selective glycogen synthase kinase-3 (GSK-3) inhibitors as potential anti-diabetic agents
    Reynet, C
    Danielsen, GM
    Bodvarsdottir, TB
    Urso, B
    Bowler, AN
    Olesen, PH
    Sorensen, AR
    Moller, NPH
    McCormack, JG
    Hansen, BF
    Kurtzhals, P
    DIABETES, 2002, 51 : A489 - A489
  • [43] Inactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism
    Theeuwes, W. F.
    Gosker, H. R.
    Langen, R. C. J.
    Verhees, K. J. P.
    Pansters, N. A. M.
    Schols, A. M. W. J.
    Remels, A. H. V.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (12): : 3075 - 3086
  • [44] Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
    Golpich, Mojtaba
    Amini, Elham
    Hemmati, Fatemeh
    Ibrahim, Norlinah Mohamed
    Rahmani, Behrouz
    Mohamed, Zahurin
    Raymond, Azman Ali
    Dargahi, Leila
    Ghasemi, Rasoul
    Ahmadiani, Abolhassan
    PHARMACOLOGICAL RESEARCH, 2015, 97 : 16 - 26
  • [45] Inhibiting glycogen synthase kinase-3 (GSK-3) prevents the development of myeloma bone disease
    Abdul, N.
    Stoop, W.
    Koopman, W.
    Djerbi, M.
    Chantry, A. D.
    Evans, H.
    Vanderkerken, K.
    Croucher, P. I.
    BONE, 2009, 44 : S53 - S54
  • [46] Novel potent pharmacological cyclin-dependent kinase inhibitors
    Wesierska-Gadek, Jozefa
    Chamrad, Ivo
    Krystof, Vladimir
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (09) : 1561 - 1581
  • [47] 3D-QSAR STUDY OF MALEIMIDE ANALOGUES AS GLYCOGEN SYNTHASE KINASE-3 (GSK-3) INHIBITORS USING CoMSIA APPROACH
    Crisan, Luminita
    Avram, Sorin
    Bora, Alina
    Kurunczi, Ludovic
    Pacureanu, Liliana
    REVUE ROUMAINE DE CHIMIE, 2015, 60 (2-3) : 183 - 188
  • [48] A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
    Thapa, Riya
    Gupta, Gaurav
    Bhat, Asif Ahmad
    Almalki, Waleed Hassan
    Alzarea, Sami I.
    Kazmi, Imran
    Saleem, Shakir
    Khan, Ruqaiyah
    Altwaijry, Najla
    Dureja, Harish
    Singh, Sachin Kumar
    Dua, Kamal
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 253
  • [49] GSK3β inhibition is involved in the neuroprotective effects of cyclin-dependent kinase inhibitors in neurons
    Vazquez de la Torre, Aurelio
    Junyent, Felix
    Folch, Jaume
    Pelegri, Carme
    Vilaplana, Jordi
    Auladell, Carme
    Beas-Zarate, Carlos
    Pallas, Merce
    Verdaguer, Ester
    Carnins, Antoni
    PHARMACOLOGICAL RESEARCH, 2012, 65 (01) : 66 - 73
  • [50] Cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors and their role in head and neck cancer
    Jeannon, JP
    Wilson, JA
    CLINICAL OTOLARYNGOLOGY, 1998, 23 (05): : 420 - 424
12345